Furthermore, we found that other MSAs are closely associated with specific comorbidities, including a significant link between anti-TIF1-γ and NPC, highlighting a regional malignancy pattern, as well as a high incidence of cardiac involvement and hyperlipidemia in patients positive for other MSAs (Group III). Here, TRIM33 is linked to nasopharyngeal carcinoma.